Showing results (241-250 of 499) with videos related to
Sort By:
Pageof 50
European Journal of Neurology|March 24, 2026
Quantitative Whole-Body Muscle MRI in Adults With Spinal Muscular Atrophy-A Sensitive Tool for Long-Time Evaluation of Disease ProgressionAlexander Mensch, Benjamin Troppa, Ilka Schneider, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 19, 2021
Sequence of proteome profiles in preclinical and symptomatic Alzheimer's diseaseXiaohang Li, Konstantinos C Tsolis, Marta J Koper, et al.Neuropathology and Applied Neurobiology|May 19, 2025
Alpha-Synuclein as a Potential Biomarker for Inclusion Body Myositis in Blood and MuscleTobias Mayer, Leila Scholle, Laura Foerster, et al.International Journal of Molecular Sciences|September 25, 2019
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy BodiesInger van Steenoven, Barbara Noli, Cristina Cocco, et al.European Journal of Neurology|November 30, 2025
MRI-DTI Biomarkers Along the Continuum of Behavioral Variant Frontotemporal DementiaMarco Michelutti, Hans-Jürgen Huppertz, Sarah Anderl-Straub, et al.Archives of General Psychiatry|February 9, 2011
The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levelsBrit-Maren M Schjeide, Cathrin Schnack, Jean-Charles Lambert, et al.Journal of Alzheimer'S Disease : JAD|April 5, 2021
Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal FluidGustaf Boström, Eva Freyhult, Johan Virhammar, et al.Neurobiology of Aging|November 22, 2005
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob diseaseKatharina Buerger, Markus Otto, Stefan J Teipel, et al.Neurobiology of Aging|July 5, 2015
Serum microRNAs in sporadic amyotrophic lateral sclerosisAxel Freischmidt, Kathrin Müller, Lisa Zondler, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 19, 2025
CSF levels of the somatodendritic protein MAP2 are increased in ALS and predict shorter survivalFederico Verde, Jakub Vávra, J Dorst, et al.Pageof 50